Thiol Isomerases Orchestrate Thrombosis and Hemostasis.

Area of Science:

• Cardiovascular Biology
• Hemostasis and Thrombosis
• Molecular Medicine

Background:

• Protein disulfide isomerase (PDI) and related thiol isomerases are critical for thrombus formation.
• These enzymes are released from platelets and vascular cells, influencing platelet integrin αIIbβ3 function.
• While generally pro-thrombotic, PDI can also decrease thrombus formation by delivering nitric oxide to platelets.

Purpose of the Study:

• To review the role of PDI in cardiovascular biology.
• To detail the mechanisms of action of thiol isomerases in thrombosis.
• To summarize current knowledge on thiol isomerase inhibitors.

Main Methods:

• Literature review of PDI and thiol isomerase research.
• Analysis of PDI's role in platelet activation and hemostasis.
• Summary of identified thiol isomerase targets and inhibitors.

Main Results:

• Thiol isomerases regulate protein folding and function at the cell surface, impacting pro-thrombotic factors.
• TMX1 is the first identified thiol isomerase to negatively regulate platelets.
• Novel selective thiol isomerase inhibitors are in clinical trials for cancer-associated thrombosis.

Conclusions:

• Thiol isomerases are central regulators of thrombus development.
• Understanding their complex roles is crucial for therapeutic interventions.
• Selective inhibitors offer a promising avenue for managing thrombotic disorders.